Abstract:Sonodynamic therapy (SDT), utilizing ultrasound (US) as the trigger, has gained popularity recently as a therapeutic approach with significant potential for treating various diseases. Metal–organic frameworks (MOFs), characterized by structural flexibility, are prominently emerging in the SDT realm as an innovative type of sonosensitizer, offering functional tunability and biocompatibility. However, due to the inherent limitations of MOFs, such as low reactivity to reactive oxygen species and challenges posed by the complex tumor microenvironment, MOF-based sonosensitizers with singular functions are unable to demonstrate the desired therapeutic efficacy and may pose risks of toxicity, limiting their biological applications to superficial tissues. MOFs generally possess distinctive crystalline structures and properties, and their controlled coordination environments provide a flexible platform for exploring structure-effect relationships and guiding the design and development of MOF-based nanomaterials to unlock their broader potential in biological fields. The primary focus of this paper is to summarize cases involving the modification of different MOF materials and the innovative strategies developed for various complex conditions. The paper outlines the diverse application areas of functionalized MOF-based sonosensitizers in tumor synergistic therapies, highlighting the extensive prospects of SDT. Additionally, challenges confronting SDT are briefly summarized to stimulate increased scientific interest in the practical application of MOFs and the successful clinical translation of SDT. Through these discussions, we strive to foster advancements that lead to early-stage clinical benefits for patients. Statement of significance 1. An overview for the progresses in SDT explored from a novel and fundamental perspective. 2. Different modification strategies to improve the MOFs-mediated SDT efficacy are provided. 3. Guidelines for the design of multifunctional MOFs-based sonosensitizers are offered. 4. Powerful tumor ablation potential is reflected in SDT-led synergistic therapies. 5. Future challenges in the field of MOFs-based SDT in clinical translation are suggested.

Film-facilitated formation of ferrocenecarboxylic acid-embedded metal-organic framework nanoparticles for sonodynamic osteosarcoma treatment

Recent Progress in Metal–organic Framework-Based Sonosensitizers for Sonodynamic Tumor Therapy

Metal–Organic Framework (MOF)‐Based Ultrasound‐Responsive Dual‐Sonosensitizer Nanoplatform for Hypoxic Cancer Therapy

A Novel Platform of MOF for Sonodynamic Therapy Advanced Therapies

Ultrasound-responsive Metal–organic Framework-Based Nanosystem for Sonodynamic Therapy/amplified Ferroptosis/ido-Blockade Osteosarcoma Immunotherapy

Magnetic Covalent Organic Framework-Based Nanoadjuvant for Multi-Amplify Sonodynamic Antitumor Therapy Effect

Ultrasmall iron-doped zinc oxide nanoparticles for ferroptosis assisted sono-chemodynamic cancer therapy

Metal-organic framework-mediated siRNA delivery and sonodynamic therapy for precisely triggering ferroptosis and augmenting ICD in osteosarcoma

Metal–organic frameworks as candidates for tumor sonodynamic therapy: Designable structures for targeted multifunctional transformation

Etching Bulk Covalent Organic Frameworks into Nanoparticles of Uniform and Controllable Size by the Molecular Exchange Etching Method for Sonodynamic and Immune Combination Antitumor Therapy.

Nanoarchitectonics with metal-organic frameworks and platinum nanozymes with improved oxygen evolution for enhanced sonodynamic/chemo-therapy

Piezoelectric-mediated two-dimensional copper-based metal-organic framework for synergistic sonodynamic and cuproptosis-driven tumor therapy

Metal–Organic Frameworks (Mof)-Assisted Sonodynamic Therapy in Anticancer Applications

Metal–Organic Frameworks Based on Fluorogens with Aggregation-Induced Emission for Enhanced Sonodynamic Therapy

Ultrasound-Triggered O2 Bombs: Perfluorobromooctane-Loaded Defect-Rich Metal-Organic Framework for Enhanced Sono-Immunotherapy

State of the art advancements in sonodynamic therapy (SDT): Metal-Organic frameworks for SDT

Metal-drug nanoparticles-mediated osteolytic microenvironment regulation for enhanced radiotherapy of orthotopic osteosarcoma

Biocompatible Fe-Hematoporphyrin coordination nanoplatforms with efficient sonodynamic-chemo effects on deep-seated tumors

Bioactive Metal–Organic Frameworks with Specific Metal–Nitrogen (M–N) Active Sites for Efficient Sonodynamic Tumor Therapy

Etching Bulk COFs into Nanoparticles of Uniform and Controllable Size by the Molecular Exchange Etching Method for Sonodynamic and Immune Combination Antitumor Therapy

Α-Fe2o3@pt Heterostructure Particles to Enable Sonodynamic Therapy with Self-Supplied O2 and Imaging-Guidance